Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFC invests $15million in India's Hikal

This article was originally published in Scrip

Executive Summary

The International Finance Corporation (IFC), a member of the World Bank group, is investing $15 million in India'sHikal by way of equity participation. Hikal plans to issue up to 1.36 million equity shares of Rs10 each on a preferential basis to IFC, the company informed the Bombay Stock Exchange. The investment will part-finance Hikal's expansion plans at its existing sites in Jigani (near Bangalore), Panoli (Gujarat) and Taloja (near Mumbai). IFC believes that by supporting Hikal, a mid-tier player in contract research and manufacturing services, it will assist in the evolution and development of an emerging industry with long-term growth prospects and strong employment potential in India. Besides by supporting process innovation in emerging markets, IFC expects Hikal to further transform itself from competing on cost to competing on process capabilities.,

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel